Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03612193 · ClinicalTrials.gov registry record

Role of the Gut Microbiome in Complex Regional Pain Syndrome

A clinical trial of Complex Regional Pain Syndromes, sponsored by Washington University School of Medicine.

Recruiting
Registry status
140
Enrollment target
1
Study location

NCT03612193: Recruiting study of Complex Regional Pain Syndromes, sponsored by Washington University School of Medicine.

NCT03612193 is a study of Complex Regional Pain Syndromes that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 140 participants, above the 86-participant average among 7 other Complex Regional Pain Syndromes trials with a reported enrollment target (63% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03612193, a study of Complex Regional Pain Syndromes, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
140 participants
Enrollment target
1
Study location

Study Summary

The objective of this prospective, observational study is to determine the association between the composition of the gut microbiota and the severity and persistence of Complex Regional Pain Syndrome symptoms (Study A). The objective of Study B, a longitudinal study of microbiota biomarkers of patients with newly diagnosed CRPS is to determine if the researchers can predict which patients are more likely to recover compared to those who do not. A secondary objective of both studies is to examine cognitive flexibility in relation to outcomes (study A and B).

Primary Outcome

Study A

Conditions Studied

Complex Regional Pain Syndromes

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2018-12-19
Est. Completion 2027-07
Washington University School of Medicine

1,502 total trials

What NCT03612193 shows while recruiting

NCT03612193 is an observational study that tracks outcomes without assigning an intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, above the 86-participant average among 7 other Complex Regional Pain Syndromes trials with a reported enrollment target (63% higher).

The record links to 1 condition, with Complex Regional Pain Syndromes appearing as the primary indexed condition, and to 0 interventions.

NCT03612193 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT03612193 about?

NCT03612193 is a clinical study titled "Role of the Gut Microbiome in Complex Regional Pain Syndrome". The objective of this prospective, observational study is to determine the association between the composition of the gut microbiota and the severity and persistence of Complex Regional Pain Syndrome symptoms (Study A). The objective of Study B, a longitudinal study of microbiota biomarkers of patie...

What is the current status of trial NCT03612193?

This trial is currently recruiting. The enrollment target is 140 participants. The study started on 2018-12-19. Estimated completion is 2027-07.

What conditions does trial NCT03612193 study?

This clinical trial studies the following conditions: Complex Regional Pain Syndromes.

Who is sponsoring clinical trial NCT03612193?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03612193 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Complex Regional Pain Syndromes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01419561 · 140 participants · Phase 2

    Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

  • NCT01624805 · 140 participants · Phase 2

    Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

  • NCT02369770 · 140 participants · NA

    Sensory-Motor Rehabilitation Post Stroke

  • NCT02455193 · 140 participants · NA

    Neuronal Effects of Exercise in Schizophrenia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT03612193

Source: ClinicalTrials.gov NCT03612193, the US trial registry maintained by the National Library of Medicine. NCT03612193 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.